The key to successful reduction of central line-associated bloodstream infections is to combine strategies from the available guidelines with the adaptive cultural changes necessary to achieve sustainable, actionable results. 

In reported events involving the use of insulin products, 52% of the events led to situations in which a patient may have or actually received the wrong dose or no dose of insulin.